In some markets, it pays to be intelligent, Jim Cramer told his Mad Money viewers Tuesday. This market isn't one of them. In fact, Cramer said, this market is for people who feel and react, not those who think and plan.
Take Tuesday's news that President Trump is withdrawing from the Iran nuclear deal, a deal he's panned since before he was a candidate. This news should have been a surprise to no one, Cramer explained, yet after the official announcement, the defense stocks rallied, with Northrop Grumman (NOC) - Get Report up 3.8%, Raytheon (RTN) - Get Report up 2.5% and Lockheed Martin (LMT) - Get Report rising 2%. In an intelligent market, Cramer said, investors would be buying the rumors and selling the news.
Then there are the oil stocks, which were also all too obviously rising on today's events. Meanwhile, other investors were piling into the airline stocks, assuming that oil prices would be cresting, when clearly they haven't.
Cramer said he's still scratching his head about the cloud stocks, as investors keep buying them day after day as if something's going on. The only problem? Nothing's going on.
This market has the memory of a Mayfly, Cramer concluded, and that means emotions rule the day, not logic. Tomorrow, we'll start fresh all over again, pretending like today never happened.
Cramer and the AAP team are using market weakness to add to their WestRock Co. (WRK) - Get Report position. Find out what they're telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS.
Off the Charts
In the "Off The Charts" segment, Cramer checked in with colleague Bob Lang over the charts of Caterpillar (CAT) - Get Report , Boeing (BA) - Get Report and United Technologies (UTX) - Get Report , three industrials that saw their stocks get crushed after comments made on their conference calls this quarter.
Lang noted that Caterpillar has been in a tailspin since its January highs but now appears in consolidation mode with the Williams oscillator and MACD momentum indicators both turning bullish.
Likewise with Boeing, which has been falling ever since trade war talks began in late February, sending shares steadily lower.
Finally, Lang noted the daily chart of United Technologies is showing strong volume, a sign of institutional buying, even as the stock has fallen below its key 200-day moving average.
For more technical analysis and to see the charts, read Which Selloffs Are Real Buying Opportunities? Cramer Goes 'Off the Charts'.
Executive Decision: Broadridge Financial Solutions
In an "Executive Decision" segment, Cramer sat down with Rich Daly, CEO of Broadridge Financial Solutions (BR) - Get Report , the 2007 spinoff of Automatic Data Processing (ADP) - Get Report that's seen its shares soar 320% over the past five years. Broadridge just reported a 21-cents-a-share earnings beat.
Daly explained that Broadridge is a trusted brand in a great space. They have a governance communications business and a capital market solutions business that totals $4 billion in revenues in an addressable market worth over $40 billion.
Broadridge provides services to retail investors, who make up a third of stock ownership in America. Every time there's a proxy vote or proxy battle, Broadridge has the technology to alert shareholders and vote their shares via telephone, online or even via mobile device. Despite being a large portion of shareholders, only 30% actually vote their shares, Daly said, a number they strive to improve every day.
Executive Decision: Valeant Pharmaceuticals
For another "Executive Decision" segment, Cramer sat down with Joe Papa, chairman and CEO of Valeant Pharmaceuticals Inc. (VRX) , which has announced it will be changing its name to Bausch Health in homage to its Bausch & Lomb brand.
Papa explained that Bausch & Lomb is a 165-year-old company with a long history of innovation, and Bausch Health honors that tradition and signifies that this company does a lot more than just pharmaceuticals. Papa said he increased research and development spending by 15% this year to help speed many new great products to market.
One of those products is Lumify, eye drops to treat dry eyes in a new way that doesn't have the rebound effect of current treatments. Papa said Bausch is also making strides in treatments for irritable bowl syndrome, or IBS, and with new leadership, that segment is again growing.
Bausch has also sold a number of non-core assets to aggressively attack their debt load and strengthen its balance sheet. Shares of the new Bausch Health were up 8.8% on the day.
In the Lightning Round, Cramer was bullish on T-Mobile US (TMUS) - Get Report , First Horizon National (FHN) - Get Report , Cullen/Frost Bankers (CFR) - Get Report , Intuitive Surgical (ISRG) - Get Report , AES Corp (AES) - Get Report , CONSOL Energy (CNX) - Get Report , Western Digital (WDC) - Get Report , Republic First Bancorp (FRBK) - Get Report and CIENA (CIEN) - Get Report .
Shares have been clinging to the $14 level, Cramer said, and while it's hard to know what each the parts of GE might be worth in a breakup or sale, there are some bright spots to consider.
Cramer said aerospace remains strong and while it's losing some market share, GE still has a huge fleet of jet engines to maintain. Then there's healthcare, where Danaher (DHR) - Get Report was reported to have offered $20 billion for GE's life sciences business. If true, there could be more a lot more value in GE Health.
But the real hidden gem might just be Baker Hughes (BHGE) - Get Report , now a GE company. With oil prices rising and likely to be strong for awhile, Baker Hughes could provide some much needed cash flow.
Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.
To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.
To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.
At the time of publication, Cramer's Action Alerts PLUS had a position in WRK, RTN, DHR.